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A sequel to these authors’ earlier comprehensive reviews which covered the field
of mammalian membrane guanylate cyclase (MGC) from its origin to the year 2010,
this article contains 13 sections. The first is historical and covers MGC from the
year 1963–1987, summarizing its colorful developmental stages from its passionate
pursuit to its consolidation. The second deals with the establishment of its biochemical
identity. MGC becomes the transducer of a hormonal signal and founder of the peptide
hormone receptor family, and creates the notion that hormone signal transduction is its
sole physiological function. The third defines its expansion. The discovery of ROS-GC
subfamily is made and it links ROS-GC with the physiology of phototransduction.
Sections ROS-GC, a Ca2+-Modulated Two Component Transduction System to Migration
Patterns and Translations of the GCAP Signals Into Production of Cyclic GMP are
Different cover its biochemistry and physiology. The noteworthy events are that
augmented by GCAPs, ROS-GC proves to be a transducer of the free Ca2+ signals
generated within neurons; ROS-GC becomes a two-component transduction system and
establishes itself as a source of cyclic GMP, the second messenger of phototransduction.
Section ROS-GC1 Gene Linked Retinal Dystrophies demonstrates how this knowledge
begins to be translated into the diagnosis and providing the molecular definition of
retinal dystrophies. Section Controlled By Low and High Levels of [Ca2+]i, ROS-GC1
is a Bimodal Transduction Switch discusses a striking property of ROS-GC where
it becomes a “[Ca2+]i bimodal switch” and transcends its signaling role in other
neural processes. In this course, discovery of the first CD-GCAP (Ca2+-dependent
guanylate cyclase activator), the S100B protein, is made. It extends the role of the
ROS-GC transduction system beyond the phototransduction to the signaling processes
in the synapse region between photoreceptor and cone ON-bipolar cells; in section
Ca2+-Modulated Neurocalcin δ ROS-GC1 Transduction System Exists in the Inner
Plexiform Layer (IPL) of the Retinal Neurons, discovery of another CD-GCAP, NCδ, is
made and its linkage with signaling of the inner plexiform layer neurons is established.
Section ROS-GC Linkage With Other Than Vision-Linked Neurons discusses linkage
of the ROS-GC transduction system with other sensory transduction processes:
Pineal gland, Olfaction and Gustation. In the next, section Evolution of a General
Ca2+-Interlocked ROS-GC Signal Transduction Concept in Sensory and Sensory-Linked
Neurons, a theoretical concept is proposed where “Ca2+-interlocked ROS-GC signal
transduction” machinery becomes a common signaling component of the sensory
and sensory-linked neurons. Closure to the review is brought by the conclusion and
future directions.
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INTRODUCTION
In addition to cyclic AMP and inositol triphosphate (IP3),
cyclic GMP is an omnipresent intracellular second messen-
ger of prokaryotes and eukaryotes. It plays a critical role in
the control of physiological processes of cardiac vasculature,
smooth muscle relaxation, blood pressure, blood volume, cel-
lular growth, sensory transduction, neural plasticity, learning,
and memory. Unique to itself, this second messenger system is
generated by the catalysis of GTP by two structurally different
guanylate cyclases, soluble and the membrane form (Figure 1).
The synthetic machinery and the modes of their operation
by which they generate cyclic GMP are entirely different, and
so are their physiologically regulated processes. This review is
focused on the mammalian membrane guanylate cyclase trans-
duction field, a principal area of research by the authors for
several decades. It begins with its historical development. Briefly
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FIGURE 1 | Soluble vs membrane guanylate cyclase. Upper panel:
Graphical representation of soluble and membrane guanylate cyclases. The
soluble form is encoded by two genes; it is heterodimeric (subunits α and β)
and requires heme for its activity. Both monomers contribute to the catalytic
center, but their orientation is unknown yet (Allerston et al., 2013). The
membrane guanylate cyclase is encoded by 7 genes. It is a single
transmembrane spanning protein. The extracelular domain (Ext) is located
outside the cell; the transmembrane domain (TM) spans the plasma
membrane; and the intracellular domain (ICD) is located inside the cell. The
active form is homodimeric. The cyclase catalytic domain is located at the
C-terminus of the protein. Both monomers in antiparallel orientation
contribute to the catalytic center (Duda et al., 2012). Lower panel: Both
cyclases are lyases (EC4.6.1.2) and catalyze synthesis of cyclic GMP from
GTP.
narrates the efforts involved building on small projects, brick
by brick, and emerged from the chasm of disbelief, through
steady, continuous work. It then moves on to its present sta-
tus. To make the presentation simple and chronologically con-
tinuous, the subject matters of the earlier reviews (Sharma
et al., 1997; Pugh et al., 1997; Sharma, 2002; Duda et al.,
2005b; Sharma, 2010; Sharma and Duda, 2012) and publica-
tion of these authors have been freely borrowed with appropriate
citations.
HISTORY: YEAR 1963–1987
BACKGROUND
The present day usage of the term “signal transduction” is rooted
in the original discovery of cyclic AMP (Sutherland and Rall,
1958; reviewed in: Sutherland and Rall, 1960) for which Earl
Wilbur Sutherland, Jr. won a Nobel Prize in physiology/medicine
in 1971. Based on the studies with glycogenmetabolism in skeletal
muscle, Sutherland’s group proposed the “second messenger”
role of cyclic AMP in the hormone actions of epinephrine and
glucagon (reviewed in Sharma et al., 1997). This “second mes-
senger” concept was revolutionary because the consensus at the
time was that the hormones acted directly on their target tissues,
and, thus the hormonal pathway could only be studied in intact
cells. Sutherland’s studies demonstrated that it was possible to
study the cell-free systems and monitor the generation of cyclic
AMP indicative of the parent hormone action. Conceptually, the
hormone action occurred in the particulate fraction of the cell
in two stages; first, the hormone interacted with the particulate
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fraction of a cell and second, generated its second messenger,
cyclic AMP.
In this concept, the hormone was the first messenger whose
interaction with its receptor resulted in a stimulus that caused
the production of the second messenger “cyclic AMP,” which
then acted as the hormone messenger in eliciting the intracel-
lular response (reviewed in Sharma et al., 1997). Thus, the term
“second messenger” was coined. Reflective of the time, the bio-
chemical nature of the receptor was not known, because none had
been purified. It was not clear whether the enzyme, termed adeny-
late cyclase, catalyzing the formation of cyclic AMP, was a separate
molecule or part, as a subunit, of the receptor. However, it was
envisioned that interaction between the receptor and adenylate
cyclase generates the second messenger. So enticing was the con-
cept that it was viewed to be applicable to all hormonal systems,
i.e., that cyclic AMP is the universal second messenger of all hor-
mones (Robison et al., 1967). Hence, the general concept evolved
in which hormone, the first messenger, transmits the extracellular
(biological) information to the interior of the cellular machinery
through the adenylate cyclase system, and the concept supposed
that the receptor was a part of the adenylate cyclase system. The
receptor was conceptualized, as defined by the studies in 1930s, as
a part of the cell where hormone, the stimulus, interacts (Clark,
1937; Ariëns and Simonis, 1966). The term “stimulus” was equiv-
alent to the presently used term “signal,” which, then, according to
the “second messenger” concept meant that adenylate cyclase was
the means to convert the extracellular ligand binding signal, into
the production of the intracellular messenger cyclic AMP. Implicit
in this concept was the understanding that the events leading to
the transformation of the hormonal binding signal into the pro-
duction of the second messenger occurred in the cell’s plasma
membrane.
The “cyclic AMP second messenger concept” was brought to
the molecular level by the discoveries of Martin Rodbell and
Alfred G. Gilman for which in 1994 they shared the Nobel Prize in
physiology/medicine. They demonstrated that G-protein signal-
ing bridged the gap between the hormonal signal and activation
of the adenylate cyclase. Rodbell’s group argued that the cellular
system that processes the hormonal signal was made up of three
separate molecular entities: (1) Discriminator (RECEPTOR); (2)
Transducer (G-Protein); (3) Amplifier, which as we understand
now is the adenylate cyclase. The surface receptor receives infor-
mation from the exterior of the cell; the G-protein (transducer)
transmigrates the information across the cell membrane; and
the amplifier (adenylate cyclase) strengthens it to initiate reac-
tions within the cell or to communicate with other cells. In
formulating this “G-Protein hormonal hypothesis” the group
demonstrated that GTP was obligatory for the hormonal action
of glucagon in liver membranes. The term TRANSDUCTION
was introduced to indicate this GTP-dependent transforma-
tion step. And usage of the term SIGNAL TRANSDUCTION
entered the field of cellular signaling (these early studies are
reviewed in Rodbell, 1978). The Gilman’s and then Birnbaumer’s
group defined the sequence of these signal transduction steps
(Hepler and Gilman, 1992; Birnbaumer and Birnbaumer, 1995).
Two types of G proteins, one stimulatory, termed Gs, and
the other inhibitory, Gi, were purified and characterized; Gs
mediated the stimulatory and Gi the inhibitory transduction.
The nature of the receptor defined the specificity of the hor-
mone. The cyclic AMP signaling system therefore comprised
of three distinct proteins—receptor, G-protein, and adenylate
cyclase (Figure 2).
Following the three-component signaling template of cyclic
AMP, phosphatidylinositol (IP3) cellular signaling pathway
evolved. Here, the surface receptor responded to an extracellular
hormonal signal and converted phosphatidyl-4,5-bisphosphate
(PIP2) in two separate second messengers, diacylglycerol and
inositol trisphosphate (IP3). IP3 signal transduction splits into
two: (1) mobilizes the intracellular calcium and (2) results in the
activation of protein kinase C (Early studies respectively reviewed
in Nishizuka, 1988; Berridge and Irvine, 1989).
In this manner, these, and complimentary studies from
other laboratories (reviewed in Strader et al., 1994) estab-
lished the presence of two major G-proteins linked with three-
component cellular signal transduction pathways—cyclic AMP
and phosphatidylinositol—providing the means by which the
extracellular hormonal signal is translated into the production
of the intracellular second messengers. These second messengers,
in turn, initiate a cascade of chemical reactions which ultimately
translate the hormonal signal into a biological response.
CYCLIC GMP SIGNALING PATHWAY
Pursuit
Besides cyclic AMP, could another cyclic nucleotide be an alterna-
tive hormonal second messenger in cellular signaling?
Cyclic GMP was first identified in rat urine (Ashman et al.,
1963). Six years later, cyclic GMP and the enzyme membrane
guanylate cyclase catalyzing its synthesis from GTP were detected
in all tested animal tissues (Goldberg et al., 1969, 1973; Ishikawa
et al., 1969). A groundbreaking “Ying Yang” hypothesis was
proposed where both cyclic AMP and cyclic GMP served as hor-
monal second messengers. They were intertwined and exhibited
opposing biological activities of the cellular regulation (Goldberg
et al., 1975).
Denial
The celebration was short lived, however. The original propo-
nents failed to consistently demonstrate a hormonally dependent
guanylate cyclase in their tested systems (Goldberg and Haddox,
1977). They observed that a variety of non-hormonal ligands
like polyunsaturated fatty acids, peroxides, hydroperoxides, free
radicals, ascorbic acid, sodium nitroprusside, cigarette smoke
also stimulated membrane guanylate cyclase activity. Thus, the
membrane guanylate cyclase was a non-specific enzyme and
underwent regulation via the oxidation-reduction potential of
the biochemical reactions (Murad et al., 1979). Also, at the time,
the only known cyclic GMP-dependent cellular component was
cyclic GMP-dependent protein kinase but not one of its spe-
cific, distinct from that of the cyclic AMP-dependent protein
kinase, substrate was known. Hence, the revised consensus was
that the cyclic GMP-dependent system lacked specificity and
acted as a sub-servant to the cyclic AMP system. Therefore, no
distinct hormonally dependent membrane guanylate cyclase or
cyclic GMP-related specific signaling system existed in any of the
biological systems and cyclic GMP had no second messenger role
in cellular signaling (Gill and McCune, 1979).
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FIGURE 2 | Comparison of the cyclic AMP (and IP3) and cyclic GMP
signaling systems. The cyclic AMP (and IP3) signaling system consists
of three separate components: hormone receptor, transducer (G protein)
and amplifier (adenylate cyclase). The cyclic GMP signaling system
consists of a single protein. The hormonal signal is recognized by the
extracellular receptor domain; the signal is potentiated at the
ATP-modulated ARM domain located next to the transmembrane domain
in the intracellular portion of the protein (transducer) and the signal is
amplified by the cyclase catalytic domain located at the C-terminus of
the protein.
With a new twist, this view was strengthened as the presence
of a soluble form of guanylate cyclase activity was found in the
originally tested systems (Murad et al., 1979). This formwas stim-
ulated by polyunsaturated fatty acids, peroxides, hydroperoxides,
free radicals and other agents. Impacted by these new findings and
a passion to pursue this new field of soluble guanylate cyclase, the
role of cyclic GMP in hormonal signal transduction was totally
discarded (Goldberg and Haddox, 1977; Murad et al., 1979).
These views are summed up in two of many high-impact reviews:
“While the metabolism of cyclic GMP has many parallelism
to that of cyclic AMP, it is becoming quite clear that the two sys-
tems have distinct differences and that the functions of one system
may not necessarily provide clues to the function of the other.
In retrospect, the apparent parallelisms of the two systems hin-
dered the originality of approaches to the cyclic GMP system and
may, in fact, have impeded some of the developments in the area.
Certainly, many early experiments with guanylate cyclase and
cyclic GMP conducted in this laboratory and others were done
based on previous experience and biases with the cyclic AMP sys-
tem . . . , the properties of the soluble and particulate activities in
tissues are quite different . . . . Minor differences have also been
noted between particulate activities and in plasma and endoplas-
mic reticulum preparations. In spite of these significant physical
and/or kinetic differences that suggest two or more forms of
guanylate cyclase may exist in tissues, it is not yet known whether
or not the proteins or their subunits are different. The apparent
differences may be attributable to assay conditions, other con-
stituents in crude preparations, or possibly other factors” (Murad
et al., 1979).
“Considerable effort has been put forth to demonstrate an acti-
vation of the enzyme by hormonal or other physiological agents
that promote the accumulation of cGMP in intact cells. To date,
no specific direct effect of such an agent on guanylate cyclase
activity in vitro has been convincingly demonstrated. This is a
characteristic of the cGMP system that contrasts sharply with its
cAMP counterpart; adenylate cyclase from disrupted cells as a
general rule can be activated by the agents that stimulate cellular
cAMP accumulation . . . .It is becoming evident that the greatest
dissimilarity between guanylate cyclase and adenylate cyclase may
be that the activity of the former is modulated indirectly with
respect to the cellular action of hormones (and other cell stimuli)
compared with the direct effect that hormones seem to have on
the activity of adenylate cyclase” (Goldberg and Haddox, 1977).
Consolidation, parallel competing concept
The above intimidating concept, lasting to the mid-1980s, was
challenged mainly by the competing concept of our group. It
favored the hormonal second messenger role of cyclic GMP
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(reviewed in Sharma, 2010). Studies with the model systems
of the isolated adrenal fasciculata and the adrenocortical carci-
noma cells established a membrane guanylate cyclase to be the
direct and specific transducer of the adrenocorticotropic hor-
mone (ACTH). Notably, ACTH had no effect on the activity of
the soluble guanylate cyclase (reviewed in Sharma, 2002). Thus,
the guanylate cyclase existed in two forms, membrane and sol-
uble; and the membrane form was hormone-dependent. These
studies are briefly outlined below.
The models of the isolated adrenal fasciculata and the adreno-
cortical carcinoma cells were tailored to have no phosphodi-
esterase activity (Kitabchi and Sharma, 1971), and they were
used to investigate the second messenger roles of cyclic AMP and
cyclic GMP in steroidogenesis. The tailoring created a height-
ened membrane response to ACTH and it was direct, reflective of
membrane-specific guanylate cyclase activity. The tailored PDE-
deleted isolated fasciculata cells were sensitive to as little as 0.5–10
μU ACTH in stimulating corticosterone synthesis (Sharma et al.,
1974, 1976; Perchellet et al., 1978). These concentrations of
ACTH did not raise the level of cyclic AMP, yet they stimulated
steroidogenesis (Sharma et al., 1974, 1976; Perchellet et al., 1978).
The rise in cyclic AMP level was observed only at ACTH concen-
trations beyond their maximal steroidogenic capacity (Sharma
et al., 1974). Thus, cyclic AMP was not the physiological second
messenger of ACTH.
The physiological levels of ACTH in these cells also generated
an excellent temporal correlation between the sequential pro-
duction of cyclic GMP, phosphorylation, and the concomitant
synthesis of corticosterone, indicating that the hormone caused
the production of cyclic GMP, this, in turn, led to phosphoryla-
tion, and finally to corticosterone synthesis (Sharma et al., 1976,
1977). On similar lines, addition of cyclic GMP to these cells stim-
ulated the protein kinase activity which was followed by a rise
in their steroidogenic activity (Sharma et al., 1976); and, impor-
tantly, this added cyclic GMPmimicked the exogenously supplied
ACTH action in stimulating the direct transformation of choles-
terol to corticosterone (Sharma et al., 1972). Consistent with
the earlier findings these studies also supported the obligatory
role of Ca2+ in the ACTH-induced steroidogenesis (Perchellet
and Sharma, 1979). The conclusions were that cyclic GMP and
Ca2+ were the two complementary physiological second messen-
gers of the hormone.
The stage was set to directly demonstrate the
ACTH-dependent membrane guanylate cyclase in the adrenal cell
membranes and also the presence of its companion cyclic GMP
system, protein kinase in the bovine adrenal cortex, to strengthen
the cyclic GMP second messenger concept.
The cyclic GMP-dependent protein kinase was purified from
the bovine adrenal cortex. Its important distinctive characteristic
that set it apart from the cyclic AMP signaling system was that its
most effective effectormolecule was 8-bromo cyclic GMP (Ahrens
et al., 1982). Compared to its dibutyryl analog, it was 10,000-fold
more active in stimulating the protein kinase activity. This feature
established its unique functional identity because the dibutyryl
cyclic AMPwasmore potent than cyclic AMP in stimulating cyclic
AMP-dependent protein kinase. Finally, the molecular structure
of the cyclic GMP-dependent protein kinase was entirely different
from that of the cyclic AMP-dependent protein kinase. The single
subunit of the former protein contained both the non-dissociable
regulatory and catalytic domains, opposite was the case with
the latter protein (Ahrens et al., 1982). Besides providing clar-
ity of the molecular elements of the cyclic GMP signaling system,
these unique characteristics of these proteins helped to resolve an
earlier argument that cyclic GMP signaling system was the “sub-
servant” of the cyclic AMP signaling system (vide supra). Clearly,
it was not the case.
Analysis of the adrenal cortex and the adrenocortical
carcinoma tissues demonstrated the direct presence of the
ACTH/Ca2+-dependent membrane guanylate cyclase (Nambi
and Sharma, 1981a,b; Nambi et al., 1982). In addition, the dis-
tinct features of the membrane and the soluble form of guanylate
cyclases were established (Table 1 of Nambi et al., 1982). Most
fundamentally, the membrane guanylate cyclase activity was not
dependent on the free radical and nitric-oxide-generating agents,
including hemin.
These conclusions were supported by the findings of other
investigators. ACTH stimulated membrane guanylate cyclase
activity in the cultured neurons (Anglard et al., 1985), and ANF
peptide hormone stimulated membrane guanylate cyclase activity
of several rat tissues (Hamet et al., 1984; Waldman et al., 1984).
Ironically, these were the same tissues, in the hands of the same
investigators, in which earlier the membrane guanylate cyclase
activity was not observed (Goldberg and Haddox, 1977; Murad
et al., 1979).
The issue was thus resolved. A hormonally-dependent
membrane guanylate cyclase existed in the mammalian cells; it
was a transducer of specific hormonal signals and cyclic GMP
was their secondmessenger. In addition, the membrane guanylate
cyclase was functionally and kinetically distinct from the soluble
form. At this moment, the task at hand was to define the cyclase’s
molecular nature and to elucidate the mechanism of the hor-
monal signal transduction.
BIOCHEMICAL IDENTITY: ATRIAL NATRIURETIC FACTOR
RECEPTOR, THE PROTOTYPE MEMBER OF THE MEMBRANE
GUANYLATE CYCLASE FAMILY
A plasma membrane guanylate cyclase was purified from the
rat adrenocortical carcinoma and its absolute purity was estab-
lished by these criteria: (1) protein staining: SDS-PAGE showed
a single Coomassie blue- and silver-stained band; (2) isoelectric
focusing, native protein and its iodinated form yielded a symmet-
rical protein peak, which superimposed over the guanylate cyclase
activity peak; (3)Western blot analysis using amonospecific poly-
clonal antibody raised against the native protein yielded a single
immunoreactive band which co-migrated with that of the puri-
fied protein; (4) the antibody raised against the native protein
blocked almost all of its membrane guanylate cyclase activity; and
(5) the protein bound ANF peptide hormone in a stoichiometric
fashion (Paul, 1986; Paul et al., 1987).
Thus, the protein was pure, it was a membrane guanylate
cyclase, and possessed a remarkable characteristic of being also
the ANF hormonal receptor. Accordingly, it was named ANF-
RGC (ANF RECEPTOR GUANYLATE CYCLASE) also known as
GC-A or NPR-A.
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The properties of ANF-RGC also resolved the earlier erroneous
conclusions on the nature of the membrane guanylate cyclase
(Goldberg andHaddox, 1977;Murad et al., 1979). Themembrane
guanylate cyclase activity was independent of the nitric-oxide-
generating agents—catalase, hemin, dithiothreitol, arachidonic
acid, and tuftsin, including cigarette smoke. These non-specific
activities apparently belonged to the soluble form of the guanylate
cyclase whose constituent, critical for the functional operation,
was heme (Figure 1).
A parallel report described the purification of a protein from
the rat lung and claimed that “ANF-binding and guanylate cyclase
activity resided on a single protein” (Kuno et al., 1986). These
authors demanded priority on their finding and challenged the
priority on the original discovery of ANF-RGC. This issue was
settled in a commentary (Sharma, 1988), which revealed that
in contrast to the criteria of the absolute purity established for
the adrenocortical carcinoma ANF-RGC guanylate cyclase (Paul
et al., 1987), the lung guanylate cyclase preparation was crude
(Kuno et al., 1986)—in addition to the main and major 120-
kD protein it contained at least 13 other minor bands and the
authors themselves stated “that it was about 95% pure” (Kuno
et al., 1986). The possibility existed that the 5% contaminant con-
tained the separate ligand-binding or the cyclase activity. There
were two other serious problems with the claim that the lung
guanylate cyclase was also the ANF receptor: (1) it bound only
14.5% of ANF at the noted theoretical value; (2) the lung enzyme
was stimulated by hemin, a characteristic of the soluble guany-
late cyclase, not possessed by the membrane guanylate cyclase
(Kuno et al., 1986). To this date, these deficiencies in the lung
enzyme to categorize it as a genuine ANF-RGC have not been
resolved.
With two subsequent reports on ANF-RGC purification from
the adrenal cortex and its characterization (Takayanagi et al.,
1987; Meloche et al., 1988), the concept that this membrane
guanylate cyclase is also a surface receptor of the ANF hormone
was established. And a new field of the hormone receptor mem-
brane guanylate cyclases was borne.
This happening had a powerful impact on the cellular sig-
nal transduction field, as it was a ground-breaker. It demon-
strated that the hormonally modulated membrane guanylate
cyclase transduction system was radically different from the
two existing cyclic AMP and IP3 signaling pathways, quoting
in the original publication “coexistence of the ANF receptor
and guanylate cyclase activities on a single polypeptide chain
indicates that the mechanism of transmembrane signal trans-
duction involving mediation by second messenger, cyclic GMP,
is different from the well-established adenylate cyclase system.
In the hormone-dependent adenylate cyclase, there is an assem-
blage of individual components—receptor, GTP-binding protein,
and catalytic moiety—for signal transduction. In contrast, the
presence of dual activities—receptor-binding and enzymic—on
a single polypeptide chain indicates that this transmembrane
protein contains both the information for signal recognition
and its translation into a second messenger” (Paul et al., 1987)
(Figure 2).
In the proposed model, ANF-RGC is depicted as a sin-
gle transmembrane-spanning protein; the ANF-receptor domain
resided on the outside, the catalytic domain protruded inside the
cell and a transmembrane segment separated its two portions
(Sharma et al., 1988; Sharma, 2002; modified version of Figure
1 in Sharma, 2002). Mechanistically, ANF will bind to its recep-
tor which resided in the extracellular domain of ANF-RGC. It will
generate a cascade of structural changes, they will be carried over
the transmembrane domain of ANF-RGC and finally stimulate
its catalytic domain residing in the interior of the cell. The cyclic
GMP will be produced and serve as a second messenger of the
hormonal ANF signal.
ANF-RGC FAMILY
Almost 3 years after its purification, ANF-RGC mRNA was
cloned from the human and rat brain (Chinkers et al., 1989;
Lowe et al., 1989), adrenal gland (Duda et al., 1991) and the
mouse Leydig tumor cells (Pandey and Singh, 1990). In all cases
the deduced protein structure validated the original theoreti-
cal prediction (Paul et al., 1987) that ANF-RGC was a single-
transmembrane-spanning protein. The transmembrane region
divides it in two roughly equal portions: extracellular and intra-
cellular (please note: a more detailed description of a representa-
tive membrane guanylate cyclase modular structure is provided in
Figure 4).
Analysis of the two additional cloned membrane guanylate
cyclases demonstrated that they were the surface receptors of
the respective hormones, CNP (Chang et al., 1989; Schulz et al.,
1989; Duda et al., 1993) and enterotoxin (de Sauvage et al., 1991;
Singh et al., 1991); and they have the identical structural topogra-
phy as ANF-RGC. According to their function, they were named
CNP-RGC (CNP receptor guanylate cyclase also known as GC-B
or NPR-B) and STa-RGC (enterotoxin receptor guanylate cyclase
also known as GC-C). These findings established a three-member
surface receptor family of membrane guanylate cyclases, which
remains the case to date (reviewed in Sharma, 2010).
HORMONE SIGNALING SITE RESIDES IN THE EXTRACELLULAR
DOMAIN OF RECEPTOR GUANYLATE CYCLASES
With the model system of the variant form of ANF-RGC, GCα,
cloned from the adrenal cortex, the original study of Duda
et al. (1991) demonstrated that the ANF binding site in ANF-
RGC resides in the extracellular domain. Compared to ANF-GC,
GCα in its structure had only two amino acid substitutions,
Gln338His and Leu364Pro, but it did not bind ANF. Importantly,
it did retain basal cyclase catalytic activity. Reconstitution of the
native ANF-RGC residues restored the mutant’s ANF-binding
and ANF-dependent catalytic activities (Duda et al., 1991).
Thus, the ANF ligand-binding domain resided in the extracel-
lular domain of ANF-RGC; and one, or both of the residues—
Gln338, Leu364—controlled its ANF-binding and ANF-dependent
catalytic activities. Refined point mutation analysis demonstrated
that both of these controls resided in Leu364 (Duda et al., 1991).
Thus, the hypothesis for the ANF signal transduction mechanism
evolved. It involved the ANF binding to its extracellular domain in
ANF-RGC; the binding initiated a cascade of structural changes in
ANF-RGC; these changes, in turn, stimulated its catalytic domain,
which resided at the opposite end on the intracellular domain
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of the cyclase. The generated cyclic GMP served as the second
messenger of ANF signal.
This signal transduction mechanistic template was applied to
CNP-RGC cloned from the human retina (Duda et al., 1993).
CNP-RGC is a homologous protein to ANF-RGC, with 59%
structural identity. It was found that Glu332 residue of CNP-RGC
was critical for the CNP binding and the CNP-dependent catalytic
activity of CNP-RGC (Duda et al., 1994). Like ANF-RGC, the site
had no influence on the basal guanylate cyclase activity. These
studies were extended to compare the identities of the folding
patterns of the external domains of these membrane guanylate
cyclases (Duda et al., 1994). They were found to be almost iden-
tical (Duda et al., 1994). The counterpart of CNP-RGC-Glu332
residue is the Gln338 residue of ANF-RGC, and that of ANF-
RGC-Leu364 residue is Val358 of CNP-RGC. Conversion of the
ANF-RGC residue Gln338 to Glu resulted in a change from none
to significant CNP signal transduction activity. And, the con-
version of Val358 to Leu generated significant ANF signal trans-
duction activity in CNP-RGC (Duda et al., 1994). These studies
validated that the ligand-binding domain resides in the extra-
cellular domain of ANF-RGC and CNP-RGC, provided identity
of the residues that are critical in defining the ligand-binding
domains and showed that the folding patterns of these domains
in two guanylate cyclases are very similar.
The subsequent crystallization studies on the isolated extra-
cellular domains of ANF-RGC and CNP-RGC validated the con-
clusions that the hormone-binding site, indeed, resides in the
external domain of the guanylate cyclase and Leu364 of ANF-
RGC and Val358 of CNP-RGC constitute critical hydrophobic sites
essential for the ANF or CNP signaling but the sites are not
the direct hormone-binding sites (Ogawa et al., 2004; He et al.,
2001).
ATP IS OBLIGATORY FOR ANF AND CNP HORMONAL SIGNALING
Prior to the molecular characterization of ANF-RGC, two stud-
ies with crude membrane preparations proposed that ATP
accelerates ANF-dependent ANF-RGC activity (Kurose et al.,
1987; Chang et al., 1990). Two different mechanisms for the
acceleration were proposed; direct (Kurose et al., 1987) and indi-
rect via an accessory protein (Chang et al., 1990). Because the
preparations were crude and the guanylate cyclase was unchar-
acterized, the issue as to which mechanism was correct could not
be resolved.
Subsequently, in parallel two independent groups established
that ATP is obligatory for the ANF-dependent ANF-RGC trans-
duction activity (Marala et al., 1991; Chinkers et al., 1991).
Neither ANF, nor ATP alone, is able to stimulate ANF-RGC cat-
alytic activity. Only when these two are together they are able
to stimulate the cyclase. Because the non-hydrolyzable analogs,
ATPγS and AMP-PNP, mimicked the ATP effect, both groups
proposed that ATP acts directly by allosteric regulation of ANF-
RGC (Marala et al., 1991; Chinkers et al., 1991). Later study
with CNP-RGC demonstrated that ATP is also obligatory for its
CNP-dependent activity (Duda et al., 1993).
The mechanistic models proposed for the ATP effect by
these two groups were different, however. Which one is valid,
was debated for over two decades. MODEL 1 proposed by the
Garbers’group stated “. . . binding of ANP [ANF] to the extra-
cellular domain of its receptor initiates a conformational change
in the protein kinase-like domain (KHD), resulting in dere-
pression of guanylate cyclase activity” (Chinkers and Garbers,
1989). Its central idea was that “KHD in native ANF-RGC sup-
presses its catalytic module activity; ANF functions by relieving
this suppression.” Sharma’s group challenged this model on the
grounds of their findings that partial or complete deletion of
the KHD did not cause any significant elevation in the basal
activity of the guanylate cyclase; therefore, ANF signaling did
not involve overcoming the KHD suppression of the guanylate
cyclase activity, contradicting the central theme of MODEL 1.
(Goraczniak et al., 1992; reviewed in Duda et al., 2005b). They
proposed an alternate MODEL 2. In it the repressor of the core
catalytic domain (CCD) of the guanylate cyclase was the disul-
fide structural motif of ANF-RGC (Duda and Sharma, 2005).
This motif was juxtaposed to the N-terminus of the TM (trans-
membrane of the domain). The motif repressed the ARM (ATP
REGULATED MODULE) domain, which, in turn, inhibited the
CCD. ATP-modulated ANF signal overcame the disulfide struc-
tural motif-dependent inhibition of ARM resulting in activation
of the CCD of ANF-RGC.
The MODEL 2 has been defined in molecular terms by simu-
lating structure of the ARM domain in 3D-terms, experimentally
validating the biochemistry of the structure and its physiology
through the mouse molecular genetic models (Duda et al., 2001c,
2009, 2013). The definition has been arrived at through biochem-
ical experiments involving point mutation, time-resolved trypto-
phan fluorescence, Forster Resonance Energy Transfer (FRET),
reconstitution, recombinant constructs, molecular modeling,
immunohistochemistry and recently mouse molecular genet-
ics (these studies are comprehensively reviewed in Duda et al.,
2014).
LINKAGE WITH SENSORY TRANSDUCTION SIGNALS
EXPANDS THE FAMILY
Because the property of being a hormonal receptor, transducer
and signal amplifier was common in all known members of the
membrane guanylate cyclase family (ANF-RGC, CNP-RGC and
STa-RGC), the notion was that the cyclic GMP signaling path-
way operated solely in the hormonal signaling pathways and was
designed to transduce only the signals generated outside the cell.
However, it was not the case.
The membrane guanylate cyclase signal transduction
paradigm changed with the landmark discovery of the pho-
toreceptor ROS-GC guanylate cyclase. Here the signal initiation
occurred inside the cell and the signal transduction system was
composed of two separate elements, Signal receiver and the
Transducer (detailed reviews Sharma and Duda, 2012; Koch
et al., 2010; Pugh et al., 1997).
It was known that in phototransduction, which is the transfor-
mation of the light signal into an electrical signal, both [Ca2+]i
and cyclic GMP are the critical cytosolic regulatory effectors of
the photon signal in the vertebrate photoreceptors. Which one
of these is the second messenger of the LIGHT signal; how these
signals are generated; how they interact with each other; and
what was the source of the cyclic GMP was not known, however
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(early reviews Pugh and Cobbs, 1986; Stryer, 1986; Lamb et al.,
1986). Early reports on the successful identification of photore-
ceptor ROS-GC contradicted each other, and created chaos. They
ranged from the guanylate cyclase being a 67 kDa subunit (Horio
and Murad, 1991a,b), consisting of “separate regulatory and cat-
alytic subunits” (Stryer, 1991) and of its molecular from of retGC
(Shyjan et al., 1992).
The breakthrough came with the seminal observation that
a soluble bovine rod outer segment (ROS) fraction stimulated
the catalytic activity of a particulate photoreceptor guanylate
cyclase in the absence of Ca2+ (Koch and Stryer, 1988). This
hinted that the guanylate cyclase was of the membrane form; the
soluble ROS fraction was Ca2+ sensitive and the two compo-
nents together constituted the phototransduction-linked guany-
late cyclase transduction element. However, the conceived struc-
ture of this guanylate cyclase was erroneous, believed to be
composed of “separate regulatory and catalytic subunits” (Stryer,
1991).
The true identity of the photoreceptor ROS-guanylate cyclase
(ROS-GC also known as GC-E) was resolved by establishing
its direct purification from the bovine outer segments (OS)
(Margulis et al., 1993), the site of phototransduction; and its
protein-sequence-based molecular cloning, structure, and func-
tion (Goraczniak et al., 1994). ROS-GC had a theoretical molec-
ular mass of 120,360 Da; a value similar to that reported earlier
for a bovine (Koch, 1991) and a toad photoreceptor guanylate
cyclase (Hayashi and Yamazaki, 1991). Unlike the other known
membrane guanylate cyclases, atrial natriuretic factor receptor
guanylate cyclase ANF-RGC (Paul et al., 1987; Sharma, 1988;
Chinkers et al., 1989; Duda et al., 1991) and type C natri-
uretic peptide CNP-RGC guanylate cyclase (Chang et al., 1989;
Duda et al., 1993), ROS-GC was not hormonally-responsive
(Goraczniak et al., 1994). And also ROS-GC was not composed
of “separate regulatory and catalytic subunits”; it was not nitric
oxide sensitive nor was its structure identical to retGC (Shyjan
et al., 1992), which apparently was a cloning artifact whose pri-
mary structure was eventually revised to match that of bovine
ROS-GC (Accession number M92432).
Hydropathy analysis of its deduced amino acid sequence
revealed that topography of this protein was similar to the
other three peptide hormone receptor guanylate cyclase mem-
bers (Goraczniak et al., 1994), i.e., (1) it was a single trans-
membrane spanning protein; (2) the TM domain divided the
protein into roughly two equal segments, extracellular and intra-
cellular; (3) it showed a significant overall homology with the
other peptide hormone receptor guanylate cyclases: 27% iden-
tity with STa-RGC, 30% with ANF-RGC, 31% with CNP-RGC.
The level of identity rose to 37, 40, and 41% in their intracel-
lular regions, and there were respective identities of 25, 32, and
32% between their kinase like domains. The least identity with
peptide hormone receptor guanylate cyclase existed in their extra-
cellular domains: 14% with STa-RGC, 17% with ANF-RGC and
18% with CNP-RGC. Despite these similarities, there were two
significant structural variances. The signature ATP-modulated
domain Gly-X-X-X-Gly present in ANF-RGC and CNP-RGC was
absent in ROS-GC. And the ROS-GC protein beyond the catalytic
domain contained a C-terminal extension tail of 90 amino acids,
Y965-K1054, this tail was absent in ANF-RGC and CNP-RGC. On
these grounds the discovery of ROS-GC represented expansion
and the generation of a new subfamily of themembrane guanylate
cyclases.
It is noteworthy that in the membrane guanylate cyclase fam-
ily ROS-GC is the only one whose molecular identity has been
established on the basis of its protein sequence. This strategy
has provided an experimental proof for the position of the N-
terminus amino acid of the mature protein and demonstrated
that the mature protein contains a 56 amino acid N-terminus
hydrophobic signal peptide. The theoretical molecular mass of
the protein with its signal peptide is 120,361 Da and without it
is 114,360 Da. (Goraczniak et al., 1994).
ROS-GC, A CA2+-MODULATED TWO COMPONENT
TRANSDUCTION SYSTEM
Following the functional description by Koch and Stryer (1988),
almost contemporaneously, two independent groups discovered
two structurally dissimilar guanylate cyclase activating proteins
(GCAPs), GCAP1 (Palczewski et al., 1994; Subbaraya et al., 1994;
Gorczyca et al., 1994; Frins et al., 1996) and GCAP2 (Dizhoor
et al., 1995). In the presence of free Ca2+, did these GCAPs inhibit
catalytic activity of the photoreceptor ROS-GC?
Availability of the recombinant (r)ROS-GC made it possible
to answer this question. Expressed in the heterologous system
of COS cells, ROS-GC was responsive at 10 nM [Ca2+]i to the
GCAP1 stimulation in a dose dependent manner. The stimulation
was inhibited cooperatively by free Ca2+ with a K1/2 of 100 nM.
Under identical conditions, GCAP1 had no effect on the catalytic
activity of the recombinant peptide hormone ANF-RGC (Duda
et al., 1996b). An important characteristic of the transduction
system was that GCAP1 remained bound to ROS-GC at the low
and high Ca2+ levels, consistent with physiological observations
(Koutalos et al., 1995). Similar reconstitution studies established
GCAP2 as another Ca2+-sensor of ROS-GC signaling. With the
subsequent discovery of a second ROS-GC, termed ROS-GC2, or
GC-F (Lowe et al., 1995) to distinguish it from the original ROS-
GC which was renamed as ROS-GC1 (GC-E), it became clear that
a Ca2+-modulated system composed of a pair of ROS-GCs and a
pair of GCAPs sub-serve phototransduction in the outer segments
of photoreceptors. Which of the two ROS-GCs is physiologically
linked with phototransduction?
This problem has not yet been solved for ROS-GC2, but by
all criteria ROS-GC1 is a vital component of the phototrans-
duction machinery. (1) It is the only one purified directly from
the ROS, the site of phototransduction. (2) Direct quantitative
estimation of the two isozyme guanylate cyclases in the bovine
ROS demonstrates that their ratios are 96% ROS-GC1 and 4%
ROS-GC2, suggesting ROS-GC2 presence is minor (Helten et al.,
2007). The latest estimation in the mouse shows the same pat-
tern, 76 vs. 24% (Peshenko et al., 2011). Notably, in contrast to
the bovine, the mouse study was made with the total OS instead
of the isolated membrane fractions. (3) The multiple cone rod
dystrophies in humans have only been linked with the ROS-GC1
mutations, none so far with ROS-GC2 (reviewed in Hunt et al.,
2010). Finally, (4) it has been demonstrated that the ROS-GC1
gene deletion results sequentially in the cone and then the rod
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degenerations, indicating that the guanylate cyclase is directly
linked with the vitality and the function of photoreceptors (Yang
et al., 1999).
GCAPS INTERLACE CA2+ AND ROS-GC
Together with recoverin (Dizhoor et al., 1991; Hurley et al., 1993),
GCAPs are the prototype members of the NCS (neuronal Ca2+
sensor) proteins family (reviewed in Sharma and Duda, 2012;
Koch et al., 2010). Except for S100B, which has two, a gen-
eral characteristic of this family is that its members have four
Ca2+-specific structural motifs, termed EF hands. They define
the general Ca2+ sensor property of the family. While the teleost
fish expresses up to 8 forms, the mammals express 2-3 GCAPs
(reviewed in: Rätscho et al., 2010).
GCAP1 and GCAP2 are expressed in the same concentration
of 3μM in the bovine ROS (Hwang et al., 2003). Their quanti-
tative, relative, and cellular concentrations in the cones are not
known. Yet immunocytochemical studies show that both GCAPs
are present in the outer and inner segments of the rods and
cones (Gorczyca et al., 1994; Frins et al., 1996). In mouse cones,
the expression of GCAP1 exceeds significantly the expression of
GCAP2 (Wen et al., 2014). Notably, GCAP1 presence in the cone
synaptic pedicles can be clearly defined (Venkataraman et al.,
2003).
True to the NCS family trait, GCAPs harbor four EF-hand
Ca2+-binding motifs, yet only three are functional (reviewed in
Koch et al., 2010; Sharma andDuda, 2012). They are second, third
and fourth. They sense Ca2+ in the range of tens to hundreds
nanomoles and are the Ca2+-sensor elements of the ROS-GC
linked phototransduction machinery.
The knowledge on the [Ca2+]i sensing properties of GCAP1
is more advanced than that of GCAP2. In a recent proposal, the
transition from the DARK State to the illuminated state of the
photoreceptors occurs by the substitution of bound Ca2+ with the
bound Mg2+ to ROS-GC1 (Peshenko and Dizhoor, 2006, 2007).
Ca2+ associates with GCAP1 with a rate of ∼ 2 × 108 M−1 s−1
(kon) which is close to the diffusion limit (Sokal et al., 1999).
The apparent dissociation constants of each EF-hand for Ca2+ are
between 0.08 and 0.9μM and between 0.1 and 1.6μM in the
absence and in the presence of 2mM Mg2+, respectively (Lim
et al., 2009). Thus, these nanomolar affinities result in fast dissoci-
ation rates (for example, koff = kon ×KD = 2×108 M−1 s−1 ×0.2
×10−6 M = 40s−1; 1/koff = 25ms), consistent with the kinetics
of the photoresponse.
GCAP2 senses Ca2+ signals differently through its second,
third, and fourth EF-hands. They display an apparent KD of
300 nM (Ames et al., 1999), but no specific assignment for the
affinity of each EF-hand has beenmade so far. It appears, however,
that EF hands two and four influence Ca2+ sensitivity of GCAP2
more than EF-hand three (Dizhoor and Hurley, 1996). Cysteine
accessibility study with GCAP2 mutants shows its restricted reac-
tivity toward Cys111 at sub-micromolar Ca2+-concentrations,
indicating that within the Ca2+ concentration range where ROS-
GCs are regulated, Ca2+-induces conformational changes in
GCAP2 (Helten and Koch, 2007). Thus, these fluctuations in the
free Ca2+ concentrations of the rods and cones control and signal
GCAPs to transmit their messages to the bound ROS-GC and be
transduced in the generation of cyclic GMP, the secondmessenger
of phototransduction.
DIFFERENTIAL ROS-GC1 MODULATION BY GCAPS
In a significant conceptual advancement, the original study of
Krishnan et al. (1998) proposed and demonstrated that “the
intracellular region of ROS-GC1 is composed of multiple mod-
ules, each designed to mediate a specific Ca2+ signaling pathway.”
This meant that the sensing mechanisms of [Ca2+]i by the ROS-
GC1 modules are more than one. This concept was arrived
at through the use of ROS-GC1 deletion and ANF-RGC/ROS-
GC1 hybrid mutants which retained only the catalytic domain
of ROS-GC1. The GCAP1- and GCAP2- modulated domains in
ROS-GC1 were separate and they resided on the opposing ends of
the catalytic domain of ROS-GC1, GCAP2 at the C-terminal side
and the GCAP1 at the N-terminal.
This concept was fine-tuned by mapping the GCAP1- and
GCAP2-modulated sites of ROS-GC1 by the use of a comprehen-
sive technology involving soluble constructs of ROS-GC1, direct
bindingmeasurements by surface plasmon resonance (SPR) spec-
troscopy, coimmunoprecipitation and functional reconstitution
utilizing progressive deletion constructs and peptide competition
studies. The GCAP1 site is composed of two subdomains: trans-
duction, M445-L456 and binding, L503-I522 (Lange et al., 1999),
and the GCAP2 of one continuous domain, Y965-N981, containing
both the transduction and the binding site (Duda et al., 2005a).
These two GCAP sites have different sensitivities to capture
[Ca2+]i signals and activate ROS-GC1. The [Ca2+] K1/2 for
GCAP1 is 707 nM and for GCAP2, 100 nM (Hwang et al., 2003).
Thus, the latter is about one-order of magnitude more sensitive
to [Ca2+]i in signaling ROS-GC1 activation.
At a secondary structural level, there also exists a striking dif-
ference between the activities of the two GCAPs. The indication
is that dimerization of GCAP2 is a necessary requisite to activate
the ROS-GC (Olshevskaya et al., 1999). In contrast, the dimeric
form of GCAP1 is inactive and does not result in activation of the
ROS-GC (Hwang et al., 2004).
GCAP-MODULATED ROS-GC1 PHOTOTRANSDUCTION
MODEL (FIGURE 3)
The biochemical process by which the rods and cones convert the
incoming LIGHT signal into the generation of the electrical sig-
nal is termed photo-transduction. Educated by the ROS specific
photoreceptor features of the interlocked GCAP/ROS-GC trans-
duction system, a model for its role in operation of the photo-
transduction machinery is proposed (Figure 3). This model
explains two principal characteristics of photo-transduction
machinery, recovery and its variable luminosity dependent oper-
ation; the latter characteristic adds an advanced feature to the
previous models (Pugh et al., 1999; Burns and Baylor, 2001;
Koch et al., 2002, 2010; Sharma, 2002; Luo et al., 2008; Stephen
et al., 2008;Wensel, 2008) and depicts the differential involvement
of GCAPs in its operation. The luminosity-dependent photo-
transduction principles of the present model incorporate a core
theme of the previously proposed “Ca2+-relay model” (Koch,
2006; reviewed in Koch et al., 2010; Sharma, 2010), which
explained the results of a transgenic GCAPs null mice study where
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FIGURE 3 | Schematic representation of the luminosity-dependent
operation of the ROS-GC-GCAP transduction system. Left panel. An
illustration of a typical vertebrate rod. In the DARK a circulating current
(arrows) is present. It is outward in the inner segment and carried primarily by
K+; in the outer segment the net charge is inward, with about 90% of the
inward flow carried by the Na+ and 10% by Ca2+ ions. Na+/K+ exchange
pumps in the inner segment membrane and Na+/K+-Ca2+ exchangers in the
outer segment membrane (see also right panels) maintain the overall ionic
gradients against the dark flows. The capture of a photon (hν) by a rhodopsin
molecule in one of the disc membranes of the outer segment initiates the
photo-transduction cascade. Right upper panel. DARK. The components of
the Photo-Transduction cascade are shown in the dark/resting steady-state.
Cytoplasmic cyclic GMP, generated by the basal catalytic activity of ROS-GC,
(Continued)
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FIGURE 3 | Continued
keeps a fraction of CNG channels in the plasma membrane open. ROS-GC1
via its 415M-L456 segment is GCAP1- and via 965Y-N981 is GCAP2-bound. Ca2+
ions enter the cell via the CNG-channel and are extruded via the Na+/K+,
Ca2+-exchanger. Synthesis and hydrolysis of cyclic GMP by ROS-GC and PDE,
respectively, occur at a low rate. The heterotrimeric G protein transducin is in
its GDP-bound state and is inactive. The Ca2+ binding proteins calmodulin
(CaM), recoverin (Rec) are bound to their target proteins, the CNG-channel,
rhodopsin kinase (Rhk), respectively. Right middle panel. Absorption of
BRIHT LIGHT by the visual pigment rhodopsin leads to the activation of the
transduction cascade: the GTP-bound α-subunit of transducin activates PDE
that rapidly hydrolyzes cGMP. Subsequently the CNG-channels close and the
Ca2+-concentration falls. The fall in cytoplasmic [Ca2+]i is sensed by
Ca2+-binding proteins: CaM dissociates from the CNG-channel what leads to
an increase in cyclic GMP sensitivity of the channel; recoverin stops inhibiting
rhodopsin kinase; rhodopsin becomes phosphorylated. Both Ca2+-free GCAPs
in their changed configurations activate ROS-GC and synthesis of cyclic GMP
increases. Arrestin (Arr) binds to phosphorylated rhodopsin and interferes
with the binding and further activation of transducin. Enhancement of cyclic
GMP synthesis brings it to its original DARK state level and termination of the
cascade, which leads to reopening of CNG channels. Right bottom panel,
DIM LIGHT. The initial fall of [Ca2+]i is selectively detected only by GCAP1. In
its Ca2+-free state GCAP1 attains the activated mode and stimulates ROS-GC
activity. GCAP2 remains Ca2+-bound and in its inhibitory mode.
the role of GCAP2 was questioned (Howes et al., 2002; Wen et al.,
2014).
MIGRATION PATTERNS AND TRANSLATIONS OF THE GCAP
SIGNALS INTO PRODUCTION OF CYCLIC GMP ARE
DIFFERENT
After settling the issue that the biochemical modes of two GCAPs
in Ca2+ signaling of the photoreceptor ROS-GC1 are different
and autonomous of each other, the next task was to analyze their
migratory pathways at the structural levels, determine the mech-
anisms involved in transmission and translation of the signals at
the CCD of ROS-GC1 into the production of cyclic GMP.
To comprehend these issues and their resolutions, Figure 4
is presented and the parts of the discussion are excerpted
(Duda et al., 2012) and briefly recounted. The study involved a
programmed domain deletion, expression, in vivo fluorescence
spectroscopy, and in vitro reconstitution experiments. The find-
ings validated (1) in structural terms that operational modes
of two GCAPs in signaling of ROS-GC1 activity are different.
GCAP1 signal transduction occurs through M445-L456 and L503-
I522 subdomains of JMD and of GCAP2 signal transduction via
the Y965-N981 subdomain of CTE. These subdomains are at the
opposite ends of CCD and they are the sites where the signal of
the respective GCAPs originates.
(2) In living cells, both GCAPs by themselves are soluble pro-
teins. Only when they are present with ROS-GC do they become
membrane bound through their specific target sites on the ROS-
GC1. Thus, ROS-GC1 is the one that bestows on them the prop-
erty of being membrane bound; the anchoring sites are M445-L456
and L503-I522 for GCAP1 and Y965-N981 for GCAP2. In accor-
dance with these conclusions, disruption of the GCAP1 anchoring
site on ROS-GC1 through mutagenesis, results in GCAP1 being a
soluble protein. In contrast, GCAP2 remains bound to this ROS-
GC1 as its activator. These results prove that the twoGCAPs signal
ROS-GC1 activation through different modes and the differences
reside in the spatial characteristics of ROS-GC1; and because ori-
entations of the two domains of their signal origins are different,
their migration pathways are different: GCAP1 downstream from
M445-L456 and L503-I522 to the P808-K1054. This assumption was
validated through the studies with the SHD-deleted ROS-GC1
mutant. Being downstream from the JMD, the site of the GCAP1
signal, and being a component of the GCAP1 signal trajectory,
deletion of the SHD disrupted the GCAP1 signaling of ROS-GC1.
But the GCAP2 signaling of the ROS-GC remained intact.
Strikingly, these results also revealed the existence of an in
intriguing signaling pathway, never observed before for the mem-
brane guanylate cyclase family. This pathway is unique to GCAP2
and runs opposite to that of GCAP1, upstream from the Y965-
N981 site in CTE to the CCD for translation of the signal into the
production of cyclic GMP (Figure 4).
(3) The CCD is a common and conserved translation site for
the GCAP1, GCAP2 and all other signals generated by the ligands
of the membrane guanylate cyclase family. The current model,
based on biochemical analysis, is one in which CCD has intrinsic
basal catalytic activity and in its isolated form exists as a homod-
imer (Venkataraman et al., 2008). Through molecular modeling,
this secondary structure has been advanced to its 3D-form, which
reveals that its two subunits are in antiparallel conformation (Liu
et al., 1997; Venkataraman et al., 2008). Is this model applicable
in depicting the 3D structure of CCD in a living cell?
It is. The studies using the bimolecular fluorescence comple-
mentation (BiFC) technique demonstrated for the first time that
in living cells, the CCD is present in its homodimeric form; and
the two subunits are fused in the antiparallel orientations (Duda
et al., 2012).
ROS-GC1 GENE LINKED RETINAL DYSTROPHIES
The disclosure of true identity, complete structure and organiza-
tion of the ROS-GC1 gene (Duda et al., 1998) and the mechanism
by which Ca2+ signal modulates its encoded ROS-GC1 enzyme
activity made it possible to investigate its role in the human reti-
nal diseases at the genetic levels and explain their biochemistry in
molecular terms. For recent comprehensive reviews on this topic
the reader is referred to (Hunt et al., 2010; Karan et al., 2010;
Sharma, 2010; earlier findings to the year 2002 are covered in
Duda and Koch, 2002; Newbold et al., 2002).
In their original study Perrault et al. (1996) demonstrated that
there is a point mutation in the human ROS-GC1 gene, F565S.
Patients inheriting this mutation are inflicted with Leber’s con-
getinal amauresis type 1 (LCA1); they are born blind or become
blind soon after birth. Identity of the GCAP1 regulatory regions
in bovine ROS-GC1 provided an opportunity to define this dys-
trophy in molecular terms (Lange et al., 1999). The human F565S
residue corresponds to the bovine F514S residue. This residue
is located in the mapped L503-I522 ROS-GC1 binding region
for GCAP1. Biochemical analysis on the heterologusly expressed
LCA1-linked ROS-GC1 mutant in COS cells demonstrated that
the point mutation causes almost complete loss (84%) of the basal
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FIGURE 4 | Pathways of GCAPs signaling of ROS-GC1 activity. Left
panel: Schematic representation of the structural topography of ROS-GC1. It
is a single transmembrane homodimer protein. The dashed lines on the right
show the defined boundaries of its segments: LS, leader sequence; ExtD,
extracellular domain; TM, transmembrane domain; ICD, intracellular domain.
All its functional domains are housed in ICD; their designated names and the
amino acid residues constituting their boundaries are indicated at the left:
JMD, juxtamembrane domain housing the indicated GCAP1-targeted domain;
KHD, kinase homology domain; SHD-signaling helix domain; CCD-core
catalytic domain; CTE-C-terminal extension housing the GCAP2-targeted
domain. It is noteworthy, that the sites targeted by the two GCAPs
(encircled) are at the opposite ends of CCD. Right panel: The two GCAP
pathways run in opposite directions. The trajectory of the GCAP1 pathway
shown in blue dashed arrow is downstream. From its origin in the JMD, it
passes through the structural domains of KHD and SHD in its course to CCD.
In contrast, the trajectory of the GCAP2 pathway (shown in pink dashed
arrow) is upstream. From its origin in the CTE, it directly flows to CCD. The
CCD exists as an antiparallel homodimer. Both GCAP signals are translated at
the CCD into the production of cyclic GMP, which serves the second
messenger of the LIGHT signals.
catalytic activity of ROS-GC1 and also of its Ca2+ sensitivity to
modulation by GCAP1 (Duda et al., 1999b). Thus, the basic struc-
tural integrity of ROS-GC1 has been deranged by the mutation
and this has also incapacitated GCAP1-modulated Ca2+ signaling
mechanism of the guanylate cyclase.
Following this lead, similar approach has been used to inves-
tigate the second type of retinal disease that correlates with
mutations of the ROS-GC1 gene. Named cone-rod dystrophy type
6 (CORD 6), patients suffering with this disease carry one or sev-
eral point mutations in the dimerization domain of ROS-GC1
(Kelsell et al., 1998). One example is ROS-GC1-E786D, R787C,
T788M mutation. The mutation deranges the dimer formation of
the guanylate cyclase and reduces the basal catalytic activity of the
ROS-GC (Duda et al., 1999a, 2000; Tucker et al., 1999). This basic
structural derangement in the guanylate cyclase, intriguingly,
increases its sensitivity to GCAP1 and GCAP2. Physiological
consequences are that there is a change in the trigger of the
Ca2+-feedback causing a shift in the response-intensity curve
to lower light intensities. These effects explain the photophobia
often reported by CORD 6 patients and the accumulating light
damage of the retina leading to loss of cone and rod vision over a
time period of decades.
CONTROLLED BY LOW AND HIGH LEVELS OF [CA2+]I,
ROS-GC1 IS A BIMODAL TRANSDUCTION SWITCH
Discovered contemporaneously with GCAPs, CD-GCAP (Ca2+-
dependent guanylate cyclase activator) is the conformational iso-
mer of S100B protein (Pozdnyakov et al., 1995, 1997; Margulis
et al., 1996; Duda et al., 1996a, 2002; Wen et al., 2012). In con-
trast to the commercial S100B that is apparently Zn2+-bound,
CD-GCAP native to the retinal neurons is Zn2+-free (Pozdnyakov
et al., 1997).
S100B possesses a striking property toward ROS-GC1 stim-
ulation that is opposite to that of GCAPs. This finding started
a new paradigm of Ca2+ signaling to the cyclic GMP pathway.
Recombinant ROS-GC1 expressed in a heterologous system of
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COS cells responds at 10 nM [Ca2+]i to GCAP1 stimulation in a
dose dependent manner. Free Ca2+ inhibits this stimulation with
a K1/2 of 100 nM (Duda et al., 1996a). Zn2+-free S100B, how-
ever, stimulates native and recombinant ROS-GC1 with a [Ca2+]
K1/2 of 400 nM. Presence and ability of the ROS-GC to couple
to GCAPs and/or to S100B places a neuronal cell under stringent
[Ca2+]i modulation. The cell can accelerate or de-accelerate the
generation of cyclic GMP; and in this manner can operate as a
Ca2+ bimodal switch. In this hypothetical scheme, the bimodal
Ca2+ ROS-GC transduction switch would be an elegant general
mechanism for neural transmissions.
This hypothesis was put to test (Duda et al., 2002). Direct
interaction between ROS-GC1 and S100B was demonstrated
by cross-linking studies utilizing bis-(sulfosuccinimidyl)suberate.
A cross-linked product between ROS-GC1 dimer and S100B
occurred. Studies with ROS-GC1 deletion constructs confined an
interaction of S100B with the C-terminus of ROS-GC1, aa731–
1054. An EC50 of 395 nM, calculated using SPR spectroscopy,
was comparable to the EC50 of 800 nM for stimulation of ROS-
GC1 by S100B. Refined analysis revealed that aa952–991 segment
of ROS-GC1 defines the S100B binding site with half maximal
binding at 198 nM. The site contained a 966RIHVNS972 motif
that was obligatory for binding and a flanking cluster of four aa
residues, 1039RRQK1042 forming a transduction site. This trans-
duction site did not contribute to S100B binding but promoted
maximal activation of ROS-GC1.
These interactive physical parameters between S100B and
ROS-GC1 were brought to the functional level in the synaptic lay-
ers of the retina where the co-presence of ROS-GC1, GCAP1 and
S100B existed (Liu et al., 1994; Cooper et al., 1995; Duda et al.,
2002). Below 200 nM, Ca2+ elicited a dose-dependent decrease
in guanylate cyclase activity with an IC50 for Ca2+ of 100 nM.
In contrast, at higher concentrations, ROS-GC activity began to
climb with an EC50 of 0.8μM. That GCAP1 is involved in the
inhibitory phase of ROS-GC1 activity was confirmed by peptide
competition experiments. A sequence motif L503-I522 in ROS-
GC1 is critical and specific for the cyclase activation by GCAP1
(Lange et al., 1999). The core motif within this domain consists
of D507-R518.
Thus, in the synapse ROS-GC1 acts as a bimodal Ca2+ trans-
duction switch. GCAP1 has the higher affinity for Ca2+ and
upon binding, lowers ROS-GC1 activity. S100B captures the high
Ca2+ signal and upon binding, stimulates ROS-GC1. This ROS-
GC1 signal transduction model is schematically diagrammed in
(Wen et al., 2012) (Figure 4: Sharma et al., 2014).
RECENT FINDINGS
ERG recordings on the retinas of themouse S100B−/− model sug-
gest that S100B up-regulates ROS-GC1 Ca2+-dependent catalytic
activity and modulates the transmission of neural signals to cone
ON-bipolar cells (Wen et al., 2012).
CA2+-MODULATED NEUROCALCIN δ ROS-GC1
TRANSDUCTION SYSTEM EXISTS IN THE INNER PLEXIFORM
LAYER (IPL) OF THE RETINA
Besides S100B, a NCS family member, neurocalcin δ (NCδ), is
present in bovine IPL (Krishnan et al., 2004; details reviewed
in Sharma and Duda, 2012). Co-expressed with ROS-GC1 in
the heterologous system of COS cells, NCδ stimulates ROS-GC1
in a Ca2+-dependent manner with a K1/2 of 0.8μM. Its target
site in the ROS-GC is V837-L858 (Venkataraman et al., 2008). In
accordance with their mutual physiological interaction, NCδ and
ROS-GC1 are present together in IPL; added presence of [Ca2+]i
stimulates native IPL ROS-GC1 activity and nM range of Ca2+
keeps NCδ ROS-GC1 bound. The Ca2+-dependent NCδ interac-
tive ROS-GC1 kinetic parameters are: without Ca2+, NCδ has no
affinity for ROS-GC1; in the presence of Ca2+, it binds ROS-GC1
with a KA of 2.3 × 106 M−1 and a KD of 4.6 ×10−7 M.
These analyses reveal that the steps of NCδ binding to and dis-
sociation from ROS-GC1 are Ca2+-dependent, they occur within
the physiological levels of Ca2+, they are direct and of moder-
ate affinity; and they occur within the time span of the visual
transduction steps. And significantly, the target site of NCδ for
ROS-GC1 is unique to itself; it does not overlap with that of S100B
or the GCAPs.
An extraordinary characteristic about the NCδ binding
domain in ROS-GC is that it resides directly within the CCD
(Venkataraman et al., 2008). This finding demonstrated that
NCδ-modulated Ca2+ signaling of ROS-GC1 occurs through a
newmodel, its principles are (1) NCδ directly interacts with CCD;
(2) it does not require the adjacent N-terminally located α-helical
dimerization domain structural element for its interaction; (3)
the CCD module, housing the site, is intrinsically active, i.e., it
has basal guanylate cyclase activity. (4) The CCDmodule by itself
is dimeric; it does not require the dimerization domain struc-
tural element for being so; and (5) the core dimeric form of the
catalytic module is directly regulated by the Ca2+-bound NCδ;
Ca2+-unbound NCδ is ineffective (Venkataraman et al., 2008).
ROS-GC LINKAGE WITH OTHER THAN VISION-LINKED
NEURONS
The very brief following sections are meant to demonstrate that
the interlocked elements of the Ca2+ sensors and ROS-GC fam-
ily are not unique to just the visual transduction processes they
expand their signaling roles to many other sensory and sensory-
linked transduction processes.
PINEAL GLAND
The bovine pineal gland embodies the Ca2+-modulated GCAP1-
and S100B-modulated ROS-GC1 transduction systems. They
exist in two separate sets of pinealocytes. In one set, in the GCAP1
mode, the ROS-GC catalytic activity is modulated by free [Ca2+]i
K1/2 of 100 nM. The second set is in the S100B mode, the ROS-
GC activity is modulated by [Ca2+]i with K1/2 of about 0.5μM.
It has been proposed that these two processes may be involved
in the dark and light states of the two types of pinealocytes
(Venkataraman et al., 1998, 2000).
OLFACTION
Following the lead observation of Duda et al. (2001b) that
GCAP1-modulated Ca2+- signaling of ROS-GC1 transduction
system is expressed in the rat olfactory bulb, its presence and
a role in odorant transduction was investigated (Duda et al.,
2001a). Prior to these studies role of the membrane guanylate
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cyclase transduction system was denied in the odorant transduc-
tion and the system was exclusively believed to be “involved in
behavioral responses induced by hormones or pheromones, pos-
sibly related to reproduction, rather than a response to specific
odorants” (Juilfs et al., 1997; Meyer et al., 2000). Yet, these studies
revealed the presence of selected components of the membrane
guanylate cyclase in the ONE-GC (GC-D) neurons. These neu-
rons were segregated from the dominant odorant linked cyclic
AMP signaling neurons.
Odorant Transduction Model (Duda and Sharma, 2009, Figure 4)
A small population of the olfactory receptor neurons (ORN) con-
tains a cyclic GMP signal transduction pathway (Juilfs et al., 1997;
Leinders-Zufall et al., 2007; Duda and Sharma, 2008; Pertzev
et al., 2010). This pathway resides at the apical region of the cilia.
Present in this region is ONE-GC. Its outer domain is a receptor
for uroguanylin (Duda and Sharma, 2008). In its inner domain, at
the C-terminus, resides the catalytic domain (Duda and Sharma,
2008). The M880-L921 segment of this domain is bound to Ca2+
sensor component NCδ. In the resting state, the ORN is in a
60–100 nM range of [Ca2+]i and ONE-GC is in its basal state.
The uroguanylin odorant signal starts by its interaction with the
receptor domain of ONE-GC (Duda and Sharma, 2008). It is
processed through two sequential steps. In step one, ONE-GC is
primed and activated minimally. In step 2, [Ca2+]i rises. With a
K1/2 of 0.3–0.8μM, Ca2+ binds NCδ facilitating its interaction
with the ONE-GC’s segmentM880-L921 (Duda and Sharma, 2008;
Duda et al., 2004); Ca2+-bound NCδ than signals full activation
of ONE-GC and maximal synthesis of cyclic GMP (reviewed in
Sharma and Duda, 2010a,b; Zufall and Munger, 2010).
It is envisioned that the operation of step 2 starts with the gen-
eration of a small amount of cyclic GMP in step 1. This pool
of cyclic GMP opens a limited number of the cyclic GMP-gated
channels causing influx of Ca2+ in the ORN. Ca2+ binds NCδ,
which then fully activates ONE-GC.
SPECIAL NOTE
There are clues that, besides NCδ, two additional Ca2+ sensors of
ONE-GC are involved in the odorant transduction. One is hip-
pocalcin (Hpca) (Krishnan et al., 2009) and the other is GCAP1
(Pertzev et al., 2010). The studies with the Hpca−/− mousemodel
and with the GCAP1-specific antibodies demonstrate that both
Ca2+ sensors are physically linked with ONE-GC and are present
in the rat and the mouse olfactory neuroepithelium region. In
addition, 35% of the total ONE-GC transduction activity is con-
trolled by GCAP1, 27% by NCδ, and 38% by Hpca (reviewed in:
Sharma and Duda, 2010a).
GUSTATION
Similar to olfaction, gustation (taste) belongs to chemical senses.
In response to the sweet, sour, salty, bitter, and umami, taste
receptor cells generate electric signal in a process called gustatory
transduction (Avenet and Lindemann, 1989; Gilbertson et al.,
2000, 2001; Herness, 2000; Lindemann, 1996). The molecular
steps in this transduction process are ill defined. Yet in a gen-
eral scheme Ca2+ is pivotal for the process; it depolarizes plasma
membrane of the given taste cell, releases the transmitter release
and functions through the CNG-gated channels, cyclic AMP and
cyclic GMP (Kolesnikov and Margolskee, 1995).
The expression of a Ca2+ signaling ROS-GC1 transduction
system in the anterior portion of the bovine gustatory epithe-
lium has been demonstrated at the biochemical, molecular and
functional levels (Duda and Sharma, 2004). The system is com-
posed of two components: the Ca2+-sensor protein, S100B and
the transducer, ROS-GC1. Co-immunoprecipitation experiments
reveal that ROS-GC1 and S100B physically interact with each
other. The precise operational mechanism of this signal trans-
duction mechanism and its physiology has yet not been decoded
(reviewed in Sharma and Duda, 2010b).
EVOLUTION OF A GENERAL CA2+-INTERLOCKED ROS-GC
SIGNAL TRANSDUCTION CONCEPT IN SENSORY AND
SENSORY-LINKED NEURONS
Extraordinary feature of the ROS-GC signal transduction system
is that it is an extremely delicate Ca2+-modulated machinery. It
is crafted impressively to do so. In a range of nM, [Ca2+]i sig-
nals produce the ROS-GC activity to its peak level and then they
decline it with a [Ca2+]i K1/2 of 100 nM. In a bimodal fashion, the
signals then accelerate it with a Ca2+ K1/2 of 500 nM to 800 nM.
The ROS-GC accomplishes the former mode through its Ca2+
sensor partners, GCAPs and the latter function through its CD-
GCAP partners. This mechanism of bimodal regulation enables
ROS-GC to generate the Ca2+-dependent pulsated levels of cyclic
GMP, which functions as a second messenger of the sensory and
sensory-linked Ca2+ transduction mechanisms. Presented illus-
trations are: (1) LIGHT signal induced GCAP-modulated ROS-
GC transduction mode in the photoreceptor cells; (2) bimodal
GCAP1 and S100B modes in the photoreceptor-cone synapse; (3)
the odorant signal–GCAP1, S100B and Hpca–regulated modes in
ONE-GC neurons and (4) not yet well-understood processes of
the pineal gland and gustation. Bestowed with this design and
clues of its linkage with physiology of the various sensory neu-
rons, these investigators have proposed that “Ca2+-modulated
ROS-GC” machinery is a central signal transduction compo-
nent of all the sensory and/or sensory-linked secondary neu-
rons. Accompanied by a nearby CNG channel, the machinery is
empowered to de-or hyper-polarize neurons, thereby affecting the
generation of action potentials (model in Figure 4 of Sharma,
2010). It becomes an elegant theoretical general mechanism for
neural transmissions.
CONCLUSION AND FUTURE DIRECTIONS
This review has briefly chronicled the events that have resulted in
the step-by-step development of the field of membrane guany-
late cyclase. Its foundation rests on the initial seminal finding
made five decades ago (1963) that cyclic GMP exists in rat urine.
Based on the conceptual framework of the cyclic AMP second
messenger, it implied the existence of a hormonally-dependent
membrane guanylate cyclase transduction system that generates
cyclic GMP in the mammalian cells. For about a decade, this
concept underwent a tortuous evolution; first, the euphoria and
then a chaos. Barring ours, and few others, most of the fash-
ionable groups denied existence of this transduction system. The
field rekindled with the first purification and characterization of
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a membrane guanylate cyclase, ANF-RGC. Surprisingly, besides
being a guanylate cyclase, it was also a hormone receptor. And,
the field of membrane guanylate cyclase was born. Yet, the notion
evolved that the membrane guanylate cyclase family is solely
represented by its hormone-receptors. The field expanded and
changed with the discovery of a Ca2+-modulated ROS-GC trans-
duction system. Yet it remained restrictive, believed to be linked
with the single physiological function of phototransduction in the
photoreceptor cells. This belief also changed with the discovery
that besides GCAPs, which are selectively linked with phototrans-
duction, other Ca2+ sensors coupled with ROS-GC exist beyond
the photoreceptor cells. Consistent with its broader role, Ca2+-
sensor S100B modulated ROS-GC transduction system is linked
with the photoreceptor-bipolar neural transmissions. In addition,
the system is also present in the pinealocytes and a ROS-GC-
variant (ONE-GC) transduction system is expressed in the rodent
olfactory systems.
Exponential expansion of the field has generated new problems
which have to be solved. Some of them are briefly outlined below.
The first at hand deals with the modes of guanylate cyclases
modulation. Have all the modulators of each cyclase been dis-
covered? Recent studies suggest that it may not be the case as
exemplified by ONE-GC. For over a decade this cyclase was con-
sidered by some groups an orphan receptor (Fulle et al., 1995;
Juilfs et al., 1997) but it is now known that it is the receptor
for odorant uroguanylin/guanylin (Leinders-Zufall et al., 2007;
Duda and Sharma, 2008; Zufall and Munger, 2010). In this new
paradigm, the extracellularly-generated odorant signal needs to
be further processed in the intracellular domain of the cyclase in a
Ca2+-dependent manner (Duda and Sharma, 2009). Thus, ONE-
GC becomes the first cross-over functional guanylate cyclase,
being modulated by both odorant peptide receptor domain and
the Ca2+-modulated domain. Howmany other guanylate cyclases
possess this feature and what is the molecular mechanism under-
lying the process of dual regulation?
Second, a new model of ANF-RGC signal transduction has
evolved (Duda et al., 2012). ANF-RGC is the bimodal switch;
one switch is the traditional ANF hormone and the other,
[Ca2+]i. [Ca2+]i signal targets directly the CCD of ANF-RGC and
increases the production of cyclic GMP. What is its mechanism
of operation? Are other hormone receptor guanylate cyclases also
bimodal switches?
Third, the ANF-RGC receptor subfamily is multifunctional.
Besides controlling the well-known processes linked with cardiac
vasculature—diuresis, fluid secretion, smooth muscle relaxation,
it also influences the processes involved in metabolic syndrome
and obesity control (Martel et al., 2010). Similarly, CNP-RGC
triggered by its hormonal CNP signal affects such diverse pro-
cesses as bone growth (Bartels et al., 2004) and axonal sprouting
in neurons (Schmidt et al., 2007, 2009). How does it achieve this
characteristic?
Transcending to the ROS-GC subfamily, it is also multifunc-
tional; linked with the physiology of visual transduction in the
retina, photoentrainment in the pineal gland, as well as odorant-
and gustatory transduction. Except for phototransduction, the
underlying molecular principles of its linkage with the other
sensory processes are lacking.
Fourth, a new model of ROS-GC1 signaling specific to cone
photoreceptors has emerged. Its key molecule is the S100B pro-
tein. Molecular principles of this model need to be deciphered.
Fifth, ill-defined information suggests that GC-G is linked with
the processes of capacitation (Kuhn et al., 2004), atmospheric
CO2 detection (Chao et al., 2010) and is also modulated by cool
ambient temperature (Mamasuew et al., 2008). The molecular
explanations for these processes are not available.
Sixth, a common trait of the membrane guanylate cyclase fam-
ily is that it is a multi-modular protein. Experimentally validated
evidence indicates that each of its modular domains is precisely
crafted to control the cyclase’s functional specificity (Sharma
and Duda, 1997). Complete function of each domain is lacking,
however. Consequently, none of the intact membrane guanylate
cyclase structures have been solved by X-ray crystallography.
Seventh, and final, the basic knowledge gained by the preced-
ing studies will be invaluable in defining the physiology of each of
the guanylate cyclases, linking them with respective pathological
states, and in the long run, in designing targeted therapies against
these pathologies.
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